Blokhin Cancer Research Center of Russia, Dept. of clinical pharmacology

Moscow, Moscow 115478

0 studies enrolling now · 1 studies all time

What they study most

Pancreatic Cancer

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma — Completed